Founded in 2015, Oxford Science Enterprises has raised over £600M to create a world-class technology ecosystem, working with the University of Oxford to build science-based businesses capable of tackling the planet’s toughest problems. The company invests in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing, and developing treatments and cures for infectious diseases. With a core portfolio of around 40 companies, Oxford Science Enterprises adopts a flexible, long-term investment approach, helping progress over 50 companies from seed to Series A, and over 20 to Series B and beyond, including 2 IPOs and 7 trade sales. The company is committed to fostering an environment that catalyses pioneering research and steers it to commercial success in an inclusive and sustainable way.